Target Name: MIR586
NCBI ID: G693171
Other Name(s): hsa-miR-586 | microRNA 586 | hsa-mir-586 | MIRN586 | MicroRNA 586

MIR586: A Promising Drug Target and Biomarker

MIR586 (hsa-miR-586) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study, and a number of studies have investigated its potential as a drug vector.

MIR586 is a microRNA (miRNA), a small non-coding RNA molecule that plays a critical role in post-transcriptional gene regulation. It is typically expressed in high levels in various tissues and cells, and has been shown to play a role in a number of biological processes, including cell growth, apoptosis, and inflammation.

One of the key features of MIR586 is its length. It has a length of 29 amino acid residues, which makes it a small molecule that can easily be synthesized and purified for use in experiments. This has made it an attractive target for researchers to study, as it is relatively easy to manipulate and can be used in a variety of cellular and molecular biology experiments.

In addition to its length, MIR586 has another feature that makes it an attractive target for drug development, its high stability. MIR586 has been shown to have high stability in various cellular environments, including cells and tissues, which makes it a good candidate for use as a drug.

MIR586 has also been shown to play a role in a number of diseases, including cancer. Studies have shown that MIR586 is downregulated in various types of cancer, and that inhibition of its expression can lead to increased cell proliferation and the development of cancer. This makes MIR586 an attractive target for cancer therapy.

Another potential application of MIR586 is its potential as a biomarker. Its expression has been shown to be associated with a number of diseases, including cancer, and it has been used in a variety of biomarker studies. For example, studies have shown that MIR586 can be used as a biomarker for cancer, and that its expression is associated with the severity of cancer-related symptoms.

In addition to its potential as a drug target and biomarker, MIR586 has also been shown to have a number of potential therapeutic applications. For example, studies have shown that MIR586 can be used to deliver small molecules to cells, including cancer cells, and that this can lead to the inhibition of cancer cell growth. Additionally, MIR586 has been shown to have anti-inflammatory effects, which makes it an attractive target for the treatment of chronic inflammatory diseases.

Overall, MIR586 is a promising target for drug development and research. Its unique structure and function, as well as its potential as a drug vector and biomarker, make it an attractive target for study and potential therapeutic applications. Further research is needed to fully understand the role of MIR586 in various biological processes and to determine its potential as a drug.

Protein Name: MicroRNA 586

More Common Targets

MIR587 | MIR588 | MIR589 | MIR590 | MIR591 | MIR592 | MIR593 | MIR595 | MIR596 | MIR597 | MIR598 | MIR599 | MIR600 | MIR600HG | MIR601 | MIR602 | MIR603 | MIR604 | MIR605 | MIR606 | MIR6068 | MIR6069 | MIR607 | MIR6070 | MIR6071 | MIR6072 | MIR6073 | MIR6074 | MIR6075 | MIR6076 | MIR6077 | MIR6078 | MIR608 | MIR6080 | MIR6081 | MIR6082 | MIR6083 | MIR6084 | MIR6085 | MIR6086 | MIR6088 | MIR6089 | MIR609 | MIR6090 | MIR610 | MIR611 | MIR612 | MIR6124 | MIR6125 | MIR6126 | MIR6127 | MIR6128 | MIR6129 | MIR613 | MIR6130 | MIR6131 | MIR6132 | MIR6133 | MIR6134 | MIR614 | MIR615 | MIR616 | MIR6165 | MIR617 | MIR618 | MIR619 | MIR620 | MIR621 | MIR622 | MIR623 | MIR624 | MIR625 | MIR626 | MIR627 | MIR628 | MIR629 | MIR630 | MIR631 | MIR632 | MIR633 | MIR634 | MIR635 | MIR636 | MIR637 | MIR638 | MIR639 | MIR640 | MIR641 | MIR642A | MIR642B | MIR643 | MIR644A | MIR645 | MIR646 | MIR646HG | MIR647 | MIR648 | MIR649 | MIR6499 | MIR650